Clorox Company (The) stock performance trend indicates that the stock price has rallied 13.76% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 9.87% . Looking at the past 52 week period, the stock price is up at 7.95% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Clorox Company (The) has a negative value of -4.18 compared to overall market performance.Based on the Stock Research the Relative Strength Index signal is in over bought territory with a range of 69.82.
Clorox Company (The) (NYSE:CLX) has tumbled 0.38% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 2.86% in the last four weeks. The stocks have underperformed the S&P 500 by 0.62% during the past week but Clorox Company (The) (NYSE:CLX) it has outperformed the index in 4 weeks by 1.69%.
Company shares have received an average consensus rating of Hold for the current week Clorox Company (The) (NYSE:CLX) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.47 points or 0.34% at $137.54 with 1,271,368 shares getting traded. Post opening the session at $138.41, the shares hit an intraday low of $137.52 and an intraday high of $138.48 and the price was in this range throughout the day. The company has a market cap of $17,642 million and the number of outstanding shares has been calculated to be 128,265,855 shares. The 52-week high of Clorox Company (The) (NYSE:CLX) is $140.47 and the 52-week low is $111.24.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Clorox Co was Upgraded by Barclays on Jan 9, 2017 to Equal Weight, Lowers Price Target to $ 111 from a previous price target of $115 .
Company has reported several Insider transactions to the SEC, on Mar 10, 2017, Benno O Dorer (Chairman & CEO) purchased 8 shares at 136.40 per share price.On Mar 2, 2017, Nikolaos A Vlahos (EVP-COO – Household) sold 25,610 shares at 136.66 per share price.On Feb 22, 2017, Thomas D Johnson (VP – Global Business Services) sold 10,626 shares at 133.39 per share price.
Clorox Co Last issued its quarterly earnings results on Feb 3, 2017. The company reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03. Analyst had a consensus of $1.22. The company had revenue of $1406.00 million for the quarter, compared to analysts expectations of $1407.64 million. The companys revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Clorox Companys business operations, represented by the aggregate of its U.S. Household Products and Canada, U.S. Specialty Products and International segments, include the production and marketing of non-durable consumer products sold primarily through grocery and other retail stores.